Biofrontera AG Sponsored ADR Operating Cash Flow Margin

Operating Cash Flow Margin of BFAGY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Cash Flow Margin growth rates and interactive chart.


Highlights and Quick Summary

  • Operating Cash Flow Margin for the quarter ending June 30, 2022 was 0.0% (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly Operating Cash Flow Margin decreased by NaN%
  • Annual Operating Cash Flow Margin for 2021 was 105.74% (a 19.01% increase from previous year)
  • Annual Operating Cash Flow Margin for 2021 was 88.85% (a -1046.22% decrease from previous year)
  • Annual Operating Cash Flow Margin for 2020 was -9.39% (a -21.55% decrease from previous year)
  • Twelve month Operating Cash Flow Margin ending June 30, 2022 was 0.0% (a NaN% decrease compared to previous quarter)
  • Twelve month trailing Operating Cash Flow Margin decreased by NaN% year-over-year
Trailing Operating Cash Flow Margin for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
0.0% 0.0% 0.0% 0.0%
Visit stockrow.com/BFAGY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Cash Flow Margin of Biofrontera AG Sponsored ADR

Most recent Operating Cash Flow Marginof BFAGY including historical data for past 10 years.

Interactive Chart of Operating Cash Flow Margin of Biofrontera AG Sponsored ADR

Biofrontera AG Sponsored ADR Operating Cash Flow Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.0% 0.0%
2021 0.0% 0.0% -74.7% 0.0% 105.74%
2020 0.0% 0.0% -12.66% 0.0% -9.39%
2019 0.0% 0.0% 0.0% -105.21%
2018 -210.99% -63.65%
2017 -529.04% -159.12% -109.1%
2016 -323.45% -167.36%

Business Profile of Biofrontera AG Sponsored ADR

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic